LMOPX Mutual Fund

NAV$41.01

Fund Essentials - as of Sep 30, 2025

Net Assets
$57M
Expense Ratio
2.52%
Dividend Yield (Current)
-
Holdings
36
Inception Date
Dec 30, 1999
Fund Family
Patient Capital Management
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+1.02%
1 Year+23.61%
3 Year+22.90%
5 Year+4.82%
10 Year+13.04%

Asset Allocation

Stocks: 94.94%
Other: 5.06%

Top Holdings

View All →
TickerNameWeight
GOOGLAlphabet Inc,class A6.44%
CCitigroup Inc.5.66%
AMZNAmazon.Com Inc5.39%
QXOQxo Inc Pipe Deal5.32%
UNHUnitedHealth Group Incorporated5.30%
Top 10 Concentration: 51.10%Report Date: Sep 30, 2025
Download all 36 holdings for LMOPX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

LMOPX Mutual Fund Overview

LMOPX Mutual Fund (Patient Opportunity Trust Class C) is managed by Patient Capital Management with $56.8M in net assets. LMOPX expense ratio is 2.52%, holding 36 positions across sectors including Financials, Consumer Discretionary, Communication Services. Inception date: 1999-12-30.

LMOPX performance shows a YTD return of 1.02%. The 1-year return is 23.61% and the 5-year return is 4.82%.

LMOPX top holdings include Alphabet Inc,class A (6.4%), Citigroup Inc. (5.7%), Amazon.Com Inc (5.4%), Qxo Inc Pipe Deal (5.3%), UnitedHealth Group Incorporated (5.3%). View all LMOPX holdings, sector breakdown, or dividend history.

LMOPX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LMOPX alternatives are available via the screener, along with tax-loss harvesting opportunities.